Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
8.12M
-
Number of holders
-
28
-
Total 13F shares, excl. options
-
2.09M
-
Shares change
-
+11.5K
-
Total reported value, excl. options
-
$8.08M
-
Value change
-
+$438K
-
Number of buys
-
4
-
Number of sells
-
-19
-
Price
-
$3.87
Significant Holders of LUMOS PHARMA INC - Common Stock (LUMO) as of Q3 2024
36 filings reported holding LUMO - LUMOS PHARMA INC - Common Stock as of Q3 2024.
LUMOS PHARMA INC - Common Stock (LUMO) has 28 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2.09M shares
of 8.12M outstanding shares and own 25.71% of the company stock.
Largest 10 shareholders include Private Advisor Group, LLC (745K shares), GOLDMAN SACHS GROUP INC (362K shares), VANGUARD GROUP INC (244K shares), RENAISSANCE TECHNOLOGIES LLC (214K shares), Jefferies Financial Group Inc. (121K shares), Greenwich Wealth Management LLC (76.3K shares), WELLS FARGO & COMPANY/MN (65K shares), GEODE CAPITAL MANAGEMENT, LLC (55.1K shares), BlackRock, Inc. (39.8K shares), and Lion Point Capital, LP (39.6K shares).
This table shows the top 28 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.